| |
Hillsborough, NJ, February 7, 2005 - Excerpta Medica announces the launch of ThrombosisClinic.com - a state-of-the-art Web site that offers a new platform for health care practitioners to access information on this critical topic. Practicing clinicians now have a new, interactive, Web-based resource to help them keep abreast of clinical developments on the prevention, diagnosis, and treatment of thrombosis. Information provided on the Web site is US-focused but will be helpful to physicians worldwide.
The information is evidence based, bringing real clinical experience from practicing health care professionals to other practicing health care professionals, in a true peer-to-peer exchange of information. The site will cover a broad base of topical information, designed around 3 key therapy sectors:
· Arterial thrombosis
· Prevention of venous thromboembolism
· Treatment of venous thromboembolism
The Web site, which will be updated on a frequent basis, features:
· Complimentary CME courses and opportunities to earn medical textbooks
· Expert commentary from thought leaders in the management of thrombosis
· Thrombosis Resource Room, featuring new information and important research tools
· Complimentary direct access to Mosby’s Drug Consult
· Live thrombosis-related Reuters News Feeds, updated Monday - Friday by 7am EST
This unique Web site is the result of an ongoing collaboration between the Advisory Council for the newly formed TRACK (Thrombosis Resource for the Advancement of Clinical Knowledge) initiative, the Elsevier Office of Continuing Medical Education, and Excerpta Medica. The program is made possible through an educational grant from Aventis, Inc.
According to Geno Merli, MD, co-chair of the TRACK initiative, “There is a real need for ongoing practical clinical information on the best practices for the management of thrombosis. Members of the TRACK initiative are working together to develop comprehensive programs that fill this need.” In addition, Deepak Bhatt, MD, TRACK co-chair (with Dr. Merli), noted, “Arterial and venous thrombosis causes a substantial amount of morbidity and mortality worldwide. The TRACK initiative aims to provide clinicians with timely information to help improve patient care.”
“We expect this Web site to meet the needs of clinicians around the country in terms of educational updates and clinical tools,” added Mark Flanick, Director of the Elsevier Office of Continuing Medical Education.
If you have questions regarding ThrombosisClinic.com, please don’t hesitate to contact ThrombosisClinic™ at thrombosis@elsevier.com.
About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications company that services global health care clients in the areas of medical education, medical communications, and publication planning. Excerpta Medica brings an experienced team of professionals from pharmaceuticals, health care, and medical publishing to deliver scientific and creative solutions. Excerpta Medica (http://www.excerptamedica.com) has offices in the US (Hillsborough, NJ) and The Netherlands (Amsterdam).
About Elsevier
Elsevier is a world-leading publisher of scientific, technical, and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7000 employees in 74 offices worldwide publish more than 1800 journals and 2200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands, and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education, and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elseviers' ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Contact:
Shaifali Patel
+1 908 281-3625
thrombosis@elsevier.com |